The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, December 29, 2020
Everest Medicines announced the first patient has been dosed in the Phase 3 registration Asian study EVER-132-002 evaluating Trodelvy versus TPC in ...
read more
Monday, December 28, 2020
Amgen announced submission of a MAA to the EMA for sotorasib, an investigational KRASG12C inhibitor, for patients with previously treated KRAS G12C-...
read more
Friday, December 25, 2020
INOVIO has dosed its first subject in a Phase 2 clinical trial evaluating DNA medicine INO-4800, its COVID-19 vaccine candidate.
read more
Wednesday, December 23, 2020
Janssen announced the submission of a BLA to the FDA seeking approval of amivantamab for the treatment of patients with metastatic NSCLC with EGFR ...
read more
Wednesday, December 23, 2020
Fusion Antibodies and Queen’s University Belfast have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 ...
read more
Tuesday, December 22, 2020
Astellas announced that a Phase 3 trial of XOSPATA plus azacitidine versus azacitidine alone in newly diagnosed FLT3mut+ AML patients who were ...
read more
Tuesday, December 22, 2020
Pfizer and BioNTech announced the CHMP of the EMA issued a positive opinion to recommend the CMA of the Pfizer-BioNTech COVID-19 vaccine for active ...
read more
Tuesday, December 22, 2020
Protagonist announced the FDA has granted Fast Track designation to PTG-300 in the treatment of polycythemia vera.
read more
Monday, December 21, 2020
BioEclipse Therapeutics announced the initiation of patient enrollment in a Phase 1 dose-escalation trial to treat refractory solid tumors.
read more
Monday, December 21, 2020
Vanda announced the FDA has approved HETLIOZ capsule and liquid formulations for nighttime sleep disturbances associated with Smith-Magenis Syndrome.
read more
Thursday, December 17, 2020
The FDA conditionally approved the Company's IDE application to initiate its U.S. pivotal ADVENT trial to evaluate the safety and effectiveness of its...
read more
Thursday, December 17, 2020
Codagenix announced the completion of dosing in a Phase 1 clinical trial of its live attenuated CodaVax-RSV vaccine, an intranasally-administered ...
read more
Thursday, December 17, 2020
NeuroTherapia announced the completion of its first-in-human study of NTRX-07.
read more
Wednesday, December 16, 2020
AstraZeneca Pharmaceuticals
AstraZeneca has initiated a trial of ION449, an investigational antisense medicine designed to reduce blood cholesterol levels in patients with ...
read more
Tuesday, December 15, 2020
RedHill Biopharma announced promising preliminary results from a preclinical study within which opaganib, a novel, orally administered SK2 selective ...
read more